269 related articles for article (PubMed ID: 19426978)
1. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
3. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
4. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
5. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
6. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
7. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
[TBL] [Abstract][Full Text] [Related]
8. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
9. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
[TBL] [Abstract][Full Text] [Related]
10. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
11. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
12. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
13. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
Soodvilai S; Jia Z; Fongsupa S; Chatsudthipong V; Yang T
Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1610-6. PubMed ID: 23077096
[TBL] [Abstract][Full Text] [Related]
15. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
16. LXR agonist T0901317 upregulates thrombomodulin expression in glomerular endothelial cells by inhibition of nuclear factor‑κB.
Ding H; Li Y; Feng Y; Chen J; Zhong X; Wang N; Wang W; Zhang P; Wang L
Mol Med Rep; 2016 Jun; 13(6):4888-96. PubMed ID: 27082844
[TBL] [Abstract][Full Text] [Related]
17. The influence of ligand-activated LXR on primary human trophoblasts.
Larkin JC; Sears SB; Sadovsky Y
Placenta; 2014 Nov; 35(11):919-24. PubMed ID: 25255963
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
Ma AZ; Song ZY; Zhang Q
BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.
Zhang X; Bai Q; Kakiyama G; Xu L; Kim JK; Pandak WM; Ren S
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):262-70. PubMed ID: 22732306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
